// App-Quantinova.ai

2203 : Deficient ADAMTS13 Activity in Ticlopidine-Associated Thrombotic Thrombocytopenic Purpura (TTP) in Populations From Japan in 2012: Validation of Findings Initially Reported in the United States in 1998 and 2000.

Researchers

Presenter

  • Masanori Matsumoto

Principal Investigators

  • Peter Georgantopoulos

  • Constance Danielson

  • Thomas L. Ortel

  • Thomas Raife

  • William F Clark

  • Gail Rock

  • X. Long Zheng

  • Dennis Raisch

  • Yoshihiro Fujimura

  • Sony Jacob

  • Brianne L Dunn

  • Zaina Parvez Qureshi

  • Nicholas Bandarenko III

  • Hau C. Kwaan

  • Jeffrey Winters

  • Ravindra Sarode

  • Joseph E Kiss

Medical Centers

  • Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States

  • University of Ottawa, Ottawa, ON, Canada

  • London Health Sciences Center, London, ON, Canada

  • Department of Blood Transfusion Medicine, Nara Medical University, Kashihara, Nara, Japan

  • Wm. Jennings Bryan Dorn VAMC

Locations

  • United States

  • Canada

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Thrombotic thrombocytopenic purpura

  • Thrombotic microangiopathy

Biomarkers

  • N/A

Drug/Treatment

  • Ticlopidine Hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved